Latest News

Our paper “A gene expression signature to select hepatocellular carcinoma patients for liver transplantation” is finally out and can be

As part of our Liquid Biopsy development pipeline, we are identifying biomarkers and developing algorithms that can change the way

Another important step in the development of HepatoPredict and an occasion for celebration: HepatoPredict is now a registered medical device

Our collaborator from the Cento Hospital Universitário de Lisboa Central (Hospital Curry Cabral) presented an oral communication and discussed our

If you are attending the annual meeting of the International Liver Transplantation Society, come hear about HepatoPredict on Saturday morning,

It is with great joy that we announce that Prof. Marina Berenguer joined Ophiomics’ advisory board. (From ILTS site) Prof.

Ophiomics (PT) and Biocartis (BE) announce today that they have entered into a collaboration regarding HepatoPredict™, a prognostic test for

🚀Off to #ArabHealth2022🇦🇪 with the #EUeic Overseas Trade Fairs ✈Programme 2.0!Do not miss the chance to visit us at the

On the last days of 2021 Ophiomics launched the fabrication of its first “production-scale” lot of the HepatoPredict kit, already

Jose Leal presented HepatoPredict at the ESSO 40, in the session Future Oncology, where he had the opportunity to discuss

It is with great joy that we announce that Prof. Christophe Duvoux joined Ophiomics’ advisory board. (From the ILTS site:)

Our team is participating in one of the largest congresses about liver diseases with the aim of joining the global

Search

Back to top Drag